GlaxoSmithKline PLC
15 Minute Delayed Share Price
Glossary
Go to Portfolio
|
Current
|
Chg
|
% Chg |
Open |
High |
Low |
Volume |
| 1,253.50 |
+13.00
|
1.05%
|
1,243.00 |
1,257.00 |
1,237.50 |
11.56m |
Share Price Chart
Broker Recommendation (11 Brokers)
STRONG SELL
STRONG BUY
HOLD
Company Background
| Sector |
Health
|
| Activities |
Engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical and health-related consumer products |
| TIDM |
GSK |
| Index |
FTSE 100, FTSE 350, Eurotop 300, S&P Europe 350, FTSE Eurotop 100, FTSE All Share, FTSE Techmark All Share |
| Listed |
LSE - Full |
Outlook
(28/10/2009)
3QT: ceo - "...I believe that the progress we have made so far provides us with a strong platform to realise our long-term objective of delivering sustainable growth for shareholders"
Latest Results
| 3rd Quarter |
30/9/2008 |
30/9/2009 |
| Turnover |
£m |
17442 |
20274 |
| Pre-tax Profit |
£m |
5263 |
5641 |
| EPS (Norm Dil.) |
p |
77.53 |
82.92 |
| Dividend |
p |
42 |
45 |
| Notes |
Figures from 2004 in accordance with IFRS |
Investment Ratios
| |
Co. |
FTSE Sector |
Market |
| PER (pr) |
x |
10.18 |
10.25 |
12.71 |
| Dividend Yield (pr) |
% |
5.24 |
4.96 |
3.88 |
| PEG (pr) |
f |
2.43 |
0.86 |
0.53 |
| ROCE |
% |
38.65 |
53.11 |
-6.97 |
| Operating Margin |
% |
32.64 |
14.64 |
10.22 |
| EPS Growth (pr) |
% |
4.19 |
4.86 |
12.48 |
| EV/EBITDA |
x |
8.16 |
7.40 |
6.57 |
| Net Gearing |
% |
133.20 |
94.63 |
158.93 |
| Net Tangible Asset Value PS |
p |
-0.75 |
-1.06 |
1.37 |
| Price to Tangible Book Value (PTBV) |
x |
-1,649.90 |
-8.13 |
0.74 |
| Price to Cashflow (PCF) |
x |
9.47 |
8.54 |
9.21 |
| Price to Sales Ratio (PSR) |
x |
2.65 |
2.61 |
2.05 |
Data provided by
Morningstar.
All rights reserved. Please read our
Terms of Use
and
Privacy Policy.
